X T L Biopharmaceuticals reported $-812000 in Operating Profit for its fiscal quarter ending in December of 2024.


Operating Profit Change Date
Alaunos Therapeutics USD -755000 395K Dec/2024
Bioline Rx USD -2303000 88K Jun/2025
Teva Pharmaceutical Industries USD 899M 380M Jun/2025
X T L Biopharmaceuticals USD -812000 48K Dec/2024